Click for best price
Biosimilars Market Size, Share 2023
| Market size in 2022 |
US$ 5893.3 million
|
Forecast Market size by 2029 |
US$ 17930 million
|
| Growth Rate |
CAGR of 17.2% |
Number of Pages |
127 Pages |
A biosimilar is a biologic medical product highly similar to another already approved biological medicine (the 'reference medicine'). Biosimilars are approved according to the same standards of pharmaceutical quality, safety and efficacy that apply to all biological medicines. Biosimilars are officially approved versions of original "innovator" products and can be manufactured when the original product's patent expires. Reference to the innovator product is an integral component of the approval.
This report aims to provide a comprehensive presentation of the global market for Biosimilars, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biosimilars. This report contains market size and forecasts of Biosimilars in global, including the following market information:
Global top five Biosimilars companies in 2022 (%)
The global Biosimilars market was valued at US$ 5893.3 million in 2022 and is projected to reach US$ 17930 million by 2029, at a CAGR of 17.2% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon) Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Biosimilars include Pfizer, Novartis, Biocon, Biogen, Fresenius Kabi AG, Boehringer Ingelheim, Merck KgaA, Mylan and Eli Lilly, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Biosimilars manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Biosimilars Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Biosimilars Market Segment Percentages, by Type, 2022 (%)
- Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon)
- Recombinant Glycosylated Proteins
Global Biosimilars Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Biosimilars Market Segment Percentages, by Application, 2022 (%)
- Oncology
- Blood Disorders
- Growth Hormonal Deficiency
- Chronic and Autoimmune Disorders
- Others
Global Biosimilars Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Biosimilars Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Biosimilars revenues in global market, 2018-2023 (Estimated), ($ millions)
- Key companies Biosimilars revenues share in global market, 2022 (%)
- Key companies Biosimilars sales in global market, 2018-2023 (Estimated), (K Units)
- Key companies Biosimilars sales share in global market, 2022 (%)
- Further, the report presents profiles of competitors in the market, key players include:
- Pfizer
- Novartis
- Biocon
- Biogen
- Fresenius Kabi AG
- Boehringer Ingelheim
- Merck KgaA
- Mylan
- Eli Lilly
- Teva Pharmaceutical
- Dr. Reddy's Laboratories
- Amgen
- Celltrion
- Samsung Biologics
- Roche
- Probiomed
- Apotex
- Chong Kun Dang
- JCR Pharmaceuticals
- Gan & Lee Pharmaceuticals
- Gedeon Richter
- Biocad
- Coherus Bioscience
- Stada Arzneimittel AG
- Outline of Major Chapters:
- Chapter 1: Introduces the definition of Biosimilars, market overview.
- Chapter 2: Global Biosimilars market size in revenue and volume.
- Chapter 3: Detailed analysis of Biosimilars manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
- Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
- Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
- Chapter 6: Sales of Biosimilars in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
- Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
- Chapter 8: Global Biosimilars capacity by region & country.
- Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
- Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
- Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Biosimilars Market, Global Outlook and Forecast 2023-2029 |
| Market size in 2022 |
US$ 5893.3 million
|
| Forecast Market size by 2029 |
US$ 17930 million
|
| Growth Rate |
CAGR of 17.2% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
127 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Biosimilars Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Biosimilars Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Biosimilars Overall Market Size
2.1 Global Biosimilars Market Size: 2022 VS 2029
2.2 Global Biosimilars Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Biosimilars Sales: 2018-2029
3 Company Landscape
3.1 Top Biosimilars Players in Global Market
3.2 Top Global Biosimilars Companies Ranked by Revenue
3.3 Global Biosimilars Revenue by Companies
3.4 Global Biosimilars Sales by Companies
3.5 Global Biosimilars Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Biosimilars Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Biosimilars Product Type
3.8 Tier 1, Tier 2 and Tier 3 Biosimilars Players in Global Market
3.8.1 List of Global Tier 1 Biosimilars Companies
3.8.2 List of Global Tier 2 and Tier 3 Biosimilars Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Biosimilars Market Size Markets, 2022 & 2029
4.1.2 Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon)
4.1.3 Recombinant Glycosylated Proteins
4.2 By Type - Global Biosimilars Revenue & Forecasts
4.2.1 By Type - Global Biosimilars Revenue, 2018-2023
4.2.2 By Type - Global Biosimilars Revenue, 2024-2029
4.2.3 By Type - Global Biosimilars Revenue Market Share, 2018-2029
4.3 By Type - Global Biosimilars Sales & Forecasts
4.3.1 By Type - Global Biosimilars Sales, 2018-2023
4.3.2 By Type - Global Biosimilars Sales, 2024-2029
4.3.3 By Type - Global Biosimilars Sales Market Share, 2018-2029
4.4 By Type - Global Biosimilars Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Biosimilars Market Size, 2022 & 2029
5.1.2 Oncology
5.1.3 Blood Disorders
5.1.4 Growth Hormonal Deficiency
5.1.5 Chronic and Autoimmune Disorders
5.1.6 Others
5.2 By Application - Global Biosimilars Revenue & Forecasts
5.2.1 By Application - Global Biosimilars Revenue, 2018-2023
5.2.2 By Application - Global Biosimilars Revenue, 2024-2029
5.2.3 By Application - Global Biosimilars Revenue Market Share, 2018-2029
5.3 By Application - Global Biosimilars Sales & Forecasts
5.3.1 By Application - Global Biosimilars Sales, 2018-2023
5.3.2 By Application - Global Biosimilars Sales, 2024-2029
5.3.3 By Application - Global Biosimilars Sales Market Share, 2018-2029
5.4 By Application - Global Biosimilars Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Biosimilars Market Size, 2022 & 2029
6.2 By Region - Global Biosimilars Revenue & Forecasts
6.2.1 By Region - Global Biosimilars Revenue, 2018-2023
6.2.2 By Region - Global Biosimilars Revenue, 2024-2029
6.2.3 By Region - Global Biosimilars Revenue Market Share, 2018-2029
6.3 By Region - Global Biosimilars Sales & Forecasts
6.3.1 By Region - Global Biosimilars Sales, 2018-2023
6.3.2 By Region - Global Biosimilars Sales, 2024-2029
6.3.3 By Region - Global Biosimilars Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Biosimilars Revenue, 2018-2029
6.4.2 By Country - North America Biosimilars Sales, 2018-2029
6.4.3 US Biosimilars Market Size, 2018-2029
6.4.4 Canada Biosimilars Market Size, 2018-2029
6.4.5 Mexico Biosimilars Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Biosimilars Revenue, 2018-2029
6.5.2 By Country - Europe Biosimilars Sales, 2018-2029
6.5.3 Germany Biosimilars Market Size, 2018-2029
6.5.4 France Biosimilars Market Size, 2018-2029
6.5.5 U.K. Biosimilars Market Size, 2018-2029
6.5.6 Italy Biosimilars Market Size, 2018-2029
6.5.7 Russia Biosimilars Market Size, 2018-2029
6.5.8 Nordic Countries Biosimilars Market Size, 2018-2029
6.5.9 Benelux Biosimilars Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Biosimilars Revenue, 2018-2029
6.6.2 By Region - Asia Biosimilars Sales, 2018-2029
6.6.3 China Biosimilars Market Size, 2018-2029
6.6.4 Japan Biosimilars Market Size, 2018-2029
6.6.5 South Korea Biosimilars Market Size, 2018-2029
6.6.6 Southeast Asia Biosimilars Market Size, 2018-2029
6.6.7 India Biosimilars Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Biosimilars Revenue, 2018-2029
6.7.2 By Country - South America Biosimilars Sales, 2018-2029
6.7.3 Brazil Biosimilars Market Size, 2018-2029
6.7.4 Argentina Biosimilars Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Biosimilars Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Biosimilars Sales, 2018-2029
6.8.3 Turkey Biosimilars Market Size, 2018-2029
6.8.4 Israel Biosimilars Market Size, 2018-2029
6.8.5 Saudi Arabia Biosimilars Market Size, 2018-2029
6.8.6 UAE Biosimilars Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Biosimilars Major Product Offerings
7.1.4 Pfizer Biosimilars Sales and Revenue in Global (2018-2023)
7.1.5 Pfizer Key News & Latest Developments
7.2 Novartis
7.2.1 Novartis Company Summary
7.2.2 Novartis Business Overview
7.2.3 Novartis Biosimilars Major Product Offerings
7.2.4 Novartis Biosimilars Sales and Revenue in Global (2018-2023)
7.2.5 Novartis Key News & Latest Developments
7.3 Biocon
7.3.1 Biocon Company Summary
7.3.2 Biocon Business Overview
7.3.3 Biocon Biosimilars Major Product Offerings
7.3.4 Biocon Biosimilars Sales and Revenue in Global (2018-2023)
7.3.5 Biocon Key News & Latest Developments
7.4 Biogen
7.4.1 Biogen Company Summary
7.4.2 Biogen Business Overview
7.4.3 Biogen Biosimilars Major Product Offerings
7.4.4 Biogen Biosimilars Sales and Revenue in Global (2018-2023)
7.4.5 Biogen Key News & Latest Developments
7.5 Fresenius Kabi AG
7.5.1 Fresenius Kabi AG Company Summary
7.5.2 Fresenius Kabi AG Business Overview
7.5.3 Fresenius Kabi AG Biosimilars Major Product Offerings
7.5.4 Fresenius Kabi AG Biosimilars Sales and Revenue in Global (2018-2023)
7.5.5 Fresenius Kabi AG Key News & Latest Developments
7.6 Boehringer Ingelheim
7.6.1 Boehringer Ingelheim Company Summary
7.6.2 Boehringer Ingelheim Business Overview
7.6.3 Boehringer Ingelheim Biosimilars Major Product Offerings
7.6.4 Boehringer Ingelheim Biosimilars Sales and Revenue in Global (2018-2023)
7.6.5 Boehringer Ingelheim Key News & Latest Developments
7.7 Merck KgaA
7.7.1 Merck KgaA Company Summary
7.7.2 Merck KgaA Business Overview
7.7.3 Merck KgaA Biosimilars Major Product Offerings
7.7.4 Merck KgaA Biosimilars Sales and Revenue in Global (2018-2023)
7.7.5 Merck KgaA Key News & Latest Developments
7.8 Mylan
7.8.1 Mylan Company Summary
7.8.2 Mylan Business Overview
7.8.3 Mylan Biosimilars Major Product Offerings
7.8.4 Mylan Biosimilars Sales and Revenue in Global (2018-2023)
7.8.5 Mylan Key News & Latest Developments
7.9 Eli Lilly
7.9.1 Eli Lilly Company Summary
7.9.2 Eli Lilly Business Overview
7.9.3 Eli Lilly Biosimilars Major Product Offerings
7.9.4 Eli Lilly Biosimilars Sales and Revenue in Global (2018-2023)
7.9.5 Eli Lilly Key News & Latest Developments
7.10 Teva Pharmaceutical
7.10.1 Teva Pharmaceutical Company Summary
7.10.2 Teva Pharmaceutical Business Overview
7.10.3 Teva Pharmaceutical Biosimilars Major Product Offerings
7.10.4 Teva Pharmaceutical Biosimilars Sales and Revenue in Global (2018-2023)
7.10.5 Teva Pharmaceutical Key News & Latest Developments
7.11 Dr. Reddy's Laboratories
7.11.1 Dr. Reddy's Laboratories Company Summary
7.11.2 Dr. Reddy's Laboratories Biosimilars Business Overview
7.11.3 Dr. Reddy's Laboratories Biosimilars Major Product Offerings
7.11.4 Dr. Reddy's Laboratories Biosimilars Sales and Revenue in Global (2018-2023)
7.11.5 Dr. Reddy's Laboratories Key News & Latest Developments
7.12 Amgen
7.12.1 Amgen Company Summary
7.12.2 Amgen Biosimilars Business Overview
7.12.3 Amgen Biosimilars Major Product Offerings
7.12.4 Amgen Biosimilars Sales and Revenue in Global (2018-2023)
7.12.5 Amgen Key News & Latest Developments
7.13 Celltrion
7.13.1 Celltrion Company Summary
7.13.2 Celltrion Biosimilars Business Overview
7.13.3 Celltrion Biosimilars Major Product Offerings
7.13.4 Celltrion Biosimilars Sales and Revenue in Global (2018-2023)
7.13.5 Celltrion Key News & Latest Developments
7.14 Samsung Biologics
7.14.1 Samsung Biologics Company Summary
7.14.2 Samsung Biologics Business Overview
7.14.3 Samsung Biologics Biosimilars Major Product Offerings
7.14.4 Samsung Biologics Biosimilars Sales and Revenue in Global (2018-2023)
7.14.5 Samsung Biologics Key News & Latest Developments
7.15 Roche
7.15.1 Roche Company Summary
7.15.2 Roche Business Overview
7.15.3 Roche Biosimilars Major Product Offerings
7.15.4 Roche Biosimilars Sales and Revenue in Global (2018-2023)
7.15.5 Roche Key News & Latest Developments
7.16 Probiomed
7.16.1 Probiomed Company Summary
7.16.2 Probiomed Business Overview
7.16.3 Probiomed Biosimilars Major Product Offerings
7.16.4 Probiomed Biosimilars Sales and Revenue in Global (2018-2023)
7.16.5 Probiomed Key News & Latest Developments
7.17 Apotex
7.17.1 Apotex Company Summary
7.17.2 Apotex Business Overview
7.17.3 Apotex Biosimilars Major Product Offerings
7.17.4 Apotex Biosimilars Sales and Revenue in Global (2018-2023)
7.17.5 Apotex Key News & Latest Developments
7.18 Chong Kun Dang
7.18.1 Chong Kun Dang Company Summary
7.18.2 Chong Kun Dang Business Overview
7.18.3 Chong Kun Dang Biosimilars Major Product Offerings
7.18.4 Chong Kun Dang Biosimilars Sales and Revenue in Global (2018-2023)
7.18.5 Chong Kun Dang Key News & Latest Developments
7.19 JCR Pharmaceuticals
7.19.1 JCR Pharmaceuticals Company Summary
7.19.2 JCR Pharmaceuticals Business Overview
7.19.3 JCR Pharmaceuticals Biosimilars Major Product Offerings
7.19.4 JCR Pharmaceuticals Biosimilars Sales and Revenue in Global (2018-2023)
7.19.5 JCR Pharmaceuticals Key News & Latest Developments
7.20 Gan & Lee Pharmaceuticals
7.20.1 Gan & Lee Pharmaceuticals Company Summary
7.20.2 Gan & Lee Pharmaceuticals Business Overview
7.20.3 Gan & Lee Pharmaceuticals Biosimilars Major Product Offerings
7.20.4 Gan & Lee Pharmaceuticals Biosimilars Sales and Revenue in Global (2018-2023)
7.20.5 Gan & Lee Pharmaceuticals Key News & Latest Developments
7.21 Gedeon Richter
7.21.1 Gedeon Richter Company Summary
7.21.2 Gedeon Richter Business Overview
7.21.3 Gedeon Richter Biosimilars Major Product Offerings
7.21.4 Gedeon Richter Biosimilars Sales and Revenue in Global (2018-2023)
7.21.5 Gedeon Richter Key News & Latest Developments
7.22 Biocad
7.22.1 Biocad Company Summary
7.22.2 Biocad Business Overview
7.22.3 Biocad Biosimilars Major Product Offerings
7.22.4 Biocad Biosimilars Sales and Revenue in Global (2018-2023)
7.22.5 Biocad Key News & Latest Developments
7.23 Coherus Bioscience
7.23.1 Coherus Bioscience Company Summary
7.23.2 Coherus Bioscience Business Overview
7.23.3 Coherus Bioscience Biosimilars Major Product Offerings
7.23.4 Coherus Bioscience Biosimilars Sales and Revenue in Global (2018-2023)
7.23.5 Coherus Bioscience Key News & Latest Developments
7.24 Stada Arzneimittel AG
7.24.1 Stada Arzneimittel AG Company Summary
7.24.2 Stada Arzneimittel AG Business Overview
7.24.3 Stada Arzneimittel AG Biosimilars Major Product Offerings
7.24.4 Stada Arzneimittel AG Biosimilars Sales and Revenue in Global (2018-2023)
7.24.5 Stada Arzneimittel AG Key News & Latest Developments
8 Global Biosimilars Production Capacity, Analysis
8.1 Global Biosimilars Production Capacity, 2018-2029
8.2 Biosimilars Production Capacity of Key Manufacturers in Global Market
8.3 Global Biosimilars Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Biosimilars Supply Chain Analysis
10.1 Biosimilars Industry Value Chain
10.2 Biosimilars Upstream Market
10.3 Biosimilars Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Biosimilars Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Biosimilars in Global Market
Table 2. Top Biosimilars Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Biosimilars Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Biosimilars Revenue Share by Companies, 2018-2023
Table 5. Global Biosimilars Sales by Companies, (K Units), 2018-2023
Table 6. Global Biosimilars Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Biosimilars Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Biosimilars Product Type
Table 9. List of Global Tier 1 Biosimilars Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Biosimilars Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Biosimilars Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Biosimilars Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Biosimilars Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Biosimilars Sales (K Units), 2018-2023
Table 15. By Type - Global Biosimilars Sales (K Units), 2024-2029
Table 16. By Application ? Global Biosimilars Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Biosimilars Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Biosimilars Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Biosimilars Sales (K Units), 2018-2023
Table 20. By Application - Global Biosimilars Sales (K Units), 2024-2029
Table 21. By Region ? Global Biosimilars Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Biosimilars Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Biosimilars Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Biosimilars Sales (K Units), 2018-2023
Table 25. By Region - Global Biosimilars Sales (K Units), 2024-2029
Table 26. By Country - North America Biosimilars Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Biosimilars Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Biosimilars Sales, (K Units), 2018-2023
Table 29. By Country - North America Biosimilars Sales, (K Units), 2024-2029
Table 30. By Country - Europe Biosimilars Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Biosimilars Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Biosimilars Sales, (K Units), 2018-2023
Table 33. By Country - Europe Biosimilars Sales, (K Units), 2024-2029
Table 34. By Region - Asia Biosimilars Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Biosimilars Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Biosimilars Sales, (K Units), 2018-2023
Table 37. By Region - Asia Biosimilars Sales, (K Units), 2024-2029
Table 38. By Country - South America Biosimilars Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Biosimilars Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Biosimilars Sales, (K Units), 2018-2023
Table 41. By Country - South America Biosimilars Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Biosimilars Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Biosimilars Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Biosimilars Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Biosimilars Sales, (K Units), 2024-2029
Table 46. Pfizer Company Summary
Table 47. Pfizer Biosimilars Product Offerings
Table 48. Pfizer Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Pfizer Key News & Latest Developments
Table 50. Novartis Company Summary
Table 51. Novartis Biosimilars Product Offerings
Table 52. Novartis Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Novartis Key News & Latest Developments
Table 54. Biocon Company Summary
Table 55. Biocon Biosimilars Product Offerings
Table 56. Biocon Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. Biocon Key News & Latest Developments
Table 58. Biogen Company Summary
Table 59. Biogen Biosimilars Product Offerings
Table 60. Biogen Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. Biogen Key News & Latest Developments
Table 62. Fresenius Kabi AG Company Summary
Table 63. Fresenius Kabi AG Biosimilars Product Offerings
Table 64. Fresenius Kabi AG Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. Fresenius Kabi AG Key News & Latest Developments
Table 66. Boehringer Ingelheim Company Summary
Table 67. Boehringer Ingelheim Biosimilars Product Offerings
Table 68. Boehringer Ingelheim Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. Boehringer Ingelheim Key News & Latest Developments
Table 70. Merck KgaA Company Summary
Table 71. Merck KgaA Biosimilars Product Offerings
Table 72. Merck KgaA Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 73. Merck KgaA Key News & Latest Developments
Table 74. Mylan Company Summary
Table 75. Mylan Biosimilars Product Offerings
Table 76. Mylan Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 77. Mylan Key News & Latest Developments
Table 78. Eli Lilly Company Summary
Table 79. Eli Lilly Biosimilars Product Offerings
Table 80. Eli Lilly Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 81. Eli Lilly Key News & Latest Developments
Table 82. Teva Pharmaceutical Company Summary
Table 83. Teva Pharmaceutical Biosimilars Product Offerings
Table 84. Teva Pharmaceutical Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 85. Teva Pharmaceutical Key News & Latest Developments
Table 86. Dr. Reddy's Laboratories Company Summary
Table 87. Dr. Reddy's Laboratories Biosimilars Product Offerings
Table 88. Dr. Reddy's Laboratories Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 89. Dr. Reddy's Laboratories Key News & Latest Developments
Table 90. Amgen Company Summary
Table 91. Amgen Biosimilars Product Offerings
Table 92. Amgen Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 93. Amgen Key News & Latest Developments
Table 94. Celltrion Company Summary
Table 95. Celltrion Biosimilars Product Offerings
Table 96. Celltrion Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 97. Celltrion Key News & Latest Developments
Table 98. Samsung Biologics Company Summary
Table 99. Samsung Biologics Biosimilars Product Offerings
Table 100. Samsung Biologics Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 101. Samsung Biologics Key News & Latest Developments
Table 102. Roche Company Summary
Table 103. Roche Biosimilars Product Offerings
Table 104. Roche Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 105. Roche Key News & Latest Developments
Table 106. Probiomed Company Summary
Table 107. Probiomed Biosimilars Product Offerings
Table 108. Probiomed Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 109. Probiomed Key News & Latest Developments
Table 110. Apotex Company Summary
Table 111. Apotex Biosimilars Product Offerings
Table 112. Apotex Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 113. Apotex Key News & Latest Developments
Table 114. Chong Kun Dang Company Summary
Table 115. Chong Kun Dang Biosimilars Product Offerings
Table 116. Chong Kun Dang Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 117. Chong Kun Dang Key News & Latest Developments
Table 118. JCR Pharmaceuticals Company Summary
Table 119. JCR Pharmaceuticals Biosimilars Product Offerings
Table 120. JCR Pharmaceuticals Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 121. JCR Pharmaceuticals Key News & Latest Developments
Table 122. Gan & Lee Pharmaceuticals Company Summary
Table 123. Gan & Lee Pharmaceuticals Biosimilars Product Offerings
Table 124. Gan & Lee Pharmaceuticals Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 125. Gan & Lee Pharmaceuticals Key News & Latest Developments
Table 126. Gedeon Richter Company Summary
Table 127. Gedeon Richter Biosimilars Product Offerings
Table 128. Gedeon Richter Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 129. Gedeon Richter Key News & Latest Developments
Table 130. Biocad Company Summary
Table 131. Biocad Biosimilars Product Offerings
Table 132. Biocad Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 133. Biocad Key News & Latest Developments
Table 134. Coherus Bioscience Company Summary
Table 135. Coherus Bioscience Biosimilars Product Offerings
Table 136. Coherus Bioscience Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 137. Coherus Bioscience Key News & Latest Developments
Table 138. Stada Arzneimittel AG Company Summary
Table 139. Stada Arzneimittel AG Biosimilars Product Offerings
Table 140. Stada Arzneimittel AG Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 141. Stada Arzneimittel AG Key News & Latest Developments
Table 142. Biosimilars Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 143. Global Biosimilars Capacity Market Share of Key Manufacturers, 2021-2023
Table 144. Global Biosimilars Production by Region, 2018-2023 (K Units)
Table 145. Global Biosimilars Production by Region, 2024-2029 (K Units)
Table 146. Biosimilars Market Opportunities & Trends in Global Market
Table 147. Biosimilars Market Drivers in Global Market
Table 148. Biosimilars Market Restraints in Global Market
Table 149. Biosimilars Raw Materials
Table 150. Biosimilars Raw Materials Suppliers in Global Market
Table 151. Typical Biosimilars Downstream
Table 152. Biosimilars Downstream Clients in Global Market
Table 153. Biosimilars Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Biosimilars Segment by Type in 2022
Figure 2. Biosimilars Segment by Application in 2022
Figure 3. Global Biosimilars Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Biosimilars Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Biosimilars Revenue, 2018-2029 (US$, Mn)
Figure 7. Biosimilars Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Biosimilars Revenue in 2022
Figure 9. By Type - Global Biosimilars Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Biosimilars Revenue Market Share, 2018-2029
Figure 11. By Type - Global Biosimilars Sales Market Share, 2018-2029
Figure 12. By Type - Global Biosimilars Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Biosimilars Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Biosimilars Revenue Market Share, 2018-2029
Figure 15. By Application - Global Biosimilars Sales Market Share, 2018-2029
Figure 16. By Application - Global Biosimilars Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Biosimilars Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Biosimilars Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Biosimilars Revenue Market Share, 2018-2029
Figure 20. By Region - Global Biosimilars Sales Market Share, 2018-2029
Figure 21. By Country - North America Biosimilars Revenue Market Share, 2018-2029
Figure 22. By Country - North America Biosimilars Sales Market Share, 2018-2029
Figure 23. US Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Biosimilars Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Biosimilars Sales Market Share, 2018-2029
Figure 28. Germany Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 29. France Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Biosimilars Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Biosimilars Sales Market Share, 2018-2029
Figure 37. China Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 41. India Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Biosimilars Revenue Market Share, 2018-2029
Figure 43. By Country - South America Biosimilars Sales Market Share, 2018-2029
Figure 44. Brazil Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Biosimilars Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Biosimilars Sales Market Share, 2018-2029
Figure 48. Turkey Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Biosimilars Revenue, (US$, Mn), 2018-2029
Figure 52. Global Biosimilars Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Biosimilars by Region, 2022 VS 2029
Figure 54. Biosimilars Industry Value Chain
Figure 55. Marketing Channels
